<p><b>A</b>) Parasite burden of intraperitoneally (ip) and subcutaneously (sc) infected animal models. Albendazole treatment was initiated at 6 weeks post-infection. Each treatment group comprised 5 infected animals. scABZ and ipABZ groups received albendazole in honey/CMC, sc-untreated and ip-untreated groups received honey/CMC without compound. The <i>P</i> values indicate the scores obtained by student's t-test in comparison with the respective untreated groups. <b>B</b>) Weight control of mice throughout the study. Representation of average weight of different experimental groups at defined timepoints during the study. Treatments were initiated at day 42 p.i. The non-infected controls are not shown. The groups were divided into route of infection (subcutaneous = sc; intraperitoneal = ip), and in albendazole-treated (scABZ; ipABZ) or non-treated (sc-untreated; ip-untreated).</p
